Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA
NCT ID: NCT03054064
Last Updated: 2020-04-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2017-02-21
2018-01-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke
NCT03980457
Improving Arm Function Using Wearable Exoskeletons
NCT05951491
Clinical Efficacy of Exoskeleton Assistance for Individuals Post-Stroke
NCT06064604
Safety Evaluation of the ReWalk ReStore Device in Subjects With Mobility Impairments Due to Stroke
NCT03499210
Mobility Training Using Exoskeletons for Functional Recovery After Stroke
NCT02128152
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All Enrolled Subjects
All enrolled subjects will receive gait training with the Indego.
Indego Exoskeleton
Six study sessions including five Indego training sessions over two weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Indego Exoskeleton
Six study sessions including five Indego training sessions over two weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Weight 250 pounds or less
* History of one sided ischemic or hemorrhagic stroke with resultant hemiparesis
* Manual Muscle Test (MMT) 4/5 in at least upper extremity
* No restrictions on time since stroke (acuity), but all subjects need to be cleared by MD for locomotor training
* No other brain abnormalities or neurological diseases/disorders
* Has not been diagnosed with more than one stroke
* Passive range of motion (PROM) at shoulders, trunk, hips, knees and ankles within functional limits for safe gait
* Skin intact where interfaces with Indego device
* Modified Ashworth Scale (MAS) for spasticity 3 or less in the lower extremities
* Absence of complicating physical or mental conditions as determined by MD that would preclude the individual from safely participating in gait training
* Must be able to follow directions and communicate basic needs, demonstrated by a Mini- Mental State Exam (MMSE) score of 18 or greater
* Pregnancy
* Colostomy bag
* Uncontrolled/untreated hyper- or hypotension
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shepherd Center, Atlanta GA
OTHER
Cedars-Sinai Medical Center
OTHER
Sheltering Arms Physical Rehabilitation Hospitals
OTHER
Shirley Ryan AbilityLab
OTHER
Kessler Foundation
OTHER
St. Charles Hospital
UNKNOWN
TIRR Memorial Hermann
OTHER
Rusk Rehabilitation
UNKNOWN
Parker Hannifin Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedars-Sinai Health System
Los Angeles, California, United States
Shepherd Center
Atlanta, Georgia, United States
Rehabilitation Institute of Chicago (Shirley Ryan AbilityLab)
Chicago, Illinois, United States
Kessler Foundation
West Orange, New Jersey, United States
St. Charles Hospital
Port Jefferson, New York, United States
TIRR Memorial Hermann
Houston, Texas, United States
Sheltering Arms Physical Rehabilitation Centers
Mechanicsville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PHIND_CVA01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.